Hyfe is extending AI to acoustics and championing technology it claims can transform the approach to cough management, leading to improved diagnoses, better treatment and superior health outcomes. CMO Peter Small explained the rationale and how AI has inspired a significant leap forward.
Cough management has always come up short. It is one of the most common reasons people seek healthcare, and yet it has not been measurable. So says Peter Small, chief medical officer at Hyfe, a US-based start-up that is combining artificial intelligence with acoustics.
Hyfe is perfecting a technology to accurately diagnose what is really behind the coughing that sends individuals rushing to their...
Many assets do not meet their pre-launch predictions, either exceeding or falling short of their forecast sales. In this article, In Vivo highlights several historic examples and the factors that influenced their unexpected performance.
In Vivo spoke with Edward Ahn, CEO of Medipost, a Korean company that has developed stem cell therapies from cord blood, on how they are working across regulatory markets to provide a novel treatment for degenerative diseases.
Leading industry experts have spoken to In Vivo about how investment, a change in mindset and a fresh approach to policy may allow Italy to kick-start its biotech ecosystem.
